GlaxoSmithKline and Johnson & Johnson contribute a total of $100 million to early-stage biotech endeavors.
The Scientist
Most Recent
Despite nervous investors and a volatile market, a courageous few biotechnology companies are taking their chances on Wall Street.
Page 1 of 1
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
